Gliclazide and Rapamune drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gliclazide (gliclazide) and Rapamune (sirolimus). Common drug interactions include acne among females and cholecystitis acute among males.

The phase IV clinical study analyzes what interactions people have when they take Gliclazide and Rapamune. It is created by eHealthMe based on reports of 71 people who take the same drugs from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Rapamune?

Rapamune has active ingredients of sirolimus. It is often used in kidney transplant. eHealthMe is studying from 13,848 Rapamune users. Check the latest studies of Rapamune.

On Jul, 28, 2026

71 people who take Gliclazide and Rapamune together, and have interactions are studied.

Gliclazide and Rapamune drug interactions.

What are the common drug interactions of Gliclazide and Rapamune, by gender? *:

female:

Acne (skin problems that cause pimples)
Alopecia (absence of hair from areas of the body)
Ovarian cyst (fluid filled sac of the ovary)
Transplant rejection (a transplant material is not worked)
Pain
Pneumonia
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Sleep disorder due to general medical condition, insomnia type (a conditions that prevent a person from getting restful sleep due to mental condition of not getting sleep)
Overdose
Drug ineffective

male:

Cholecystitis acute (rapid infection of gallbladder)
Renal failure acute (rapid kidney dysfunction)
Gastro-oesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Gastroenteritis helicobacter (inflammation of stomach and intestine caused by helicobacter infection)
Glomerular filtration rate decreased
Immunosuppressant drug level increased
Kidney transplant rejection
Metastases to liver (cancer spreads to liver)
Nausea (feeling of having an urge to vomit)
Nephropathy toxic (damage to kidney due to toxins)

What are the common drug interactions of Gliclazide and Rapamune, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Acne (skin problems that cause pimples)
Alopecia (absence of hair from areas of the body)
Ovarian cyst (fluid filled sac of the ovary)
Transplant rejection (a transplant material is not worked)
Pain
Pneumonia
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
Sleep disorder due to general medical condition, insomnia type (a conditions that prevent a person from getting restful sleep due to mental condition of not getting sleep)
Overdose
Drug ineffective

50-59:

Cholecystitis acute (rapid infection of gallbladder)

60+:

Renal failure acute (rapid kidney dysfunction)
Drug level increased
Blood creatinine increased
Blood potassium increased
Blood urea increased
Glomerular filtration rate decreased
Immunosuppressant drug level increased
Kidney transplant rejection
Nephropathy toxic (damage to kidney due to toxins)
Proteinuria (presence of protein in the urine)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 46 people, 64.79%
Transplant Rejection (a transplant material is not worked): 9 people, 12.68%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 4 people, 5.63%
Muscle Aches (muscle pain): 4 people, 5.63%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and Rapamune?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously